Making the leap from research laboratory to clinic: Challenges and opportunities for next-generation sequencing in infectious disease diagnostics

mBio

Volumn 6, Issue 6, 2015, Pages

  Goldberg, Brittany ^a   Sichtig, Heike ^b   Geyer, Chelsie ^c   Ledeboer, Nathan ^d   Weinstock, George M ^e  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c American Society for Microbiology   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; DNA SEQUENCE; FOOD AND DRUG ADMINISTRATION; GENOME ANALYSIS; HUMAN; INFECTION; MEASUREMENT ACCURACY; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL IDENTIFICATION; MICROORGANISM DETECTION; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEQUENCE DATABASE; COMMUNICABLE DISEASES; HEALTH CARE ORGANIZATION; HIGH THROUGHPUT SEQUENCING; MICROBIOLOGICAL EXAMINATION; PROCEDURES; STANDARDS; TRENDS; UNITED STATES;

COMMUNICABLE DISEASES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; SOCIETIES, SCIENTIFIC; UNITED STATES;

EID: 84952836879     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01888-15     Document Type: Review

References (36)

1. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, Dewell SB, Du L, Fierro JM, Gomes XV, Goodwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer MLI, Jarvie TP, Jirage KB, Kim J-B, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna M, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM. 2005. Genome sequencing in open microfabricated high density picoliter reactors. Nature 437:376-380.
2. Liu L, Li Y, Li S, Hu N, He Y, Pong R, Lin D, Lu L, Law M. 2012. Comparison of next-generation sequencing systems. J Biomed Biotechnol 2012:1-11. http://dx.doi.org/10.1155/2012/251364.
3. Brown JR, Morfopoulou S, Hubb J, Emmett WA, Ip W, Shah D, Brooks T, Paine SML, Anderson G, Virasami A, Tong CYW, Clark DA, Plagnol V, Jacques TS, Qasim W, Hubank M, Breuer J. 2015. Astrovirus VA1/ HMO-C: an increasingly recognized neurotropic pathogen in immunocompromised patients. Clin Infect Dis 60:881-888. http://dx.doi.org/ 10.1093/cid/ciu940.
4. Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, Salamat SM, Somasekar S, Federman S, Miller S, Sokolic R, Garabedian E, Candotti F, Buckley RH, Reed KD, Meyer TL, Seroogy CM, Galloway R, Henderson SL, Gern JE, DeRisi JL, Chiu CY. 2014. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:2408-2417. http://dx.doi.org/10.1056/NEJMoa1401268.
5. Naccache SN, Peggs KS, Mattes FM, Phadke R, Garson JA, Grant P, Samayoa E, Federman S, Miller S, Lunn MP, Gant V, Chiu CY. 2015. Diagnosis of neuroinvasive astrovirus infection in an immunocompromised adult with encephalitis by unbiased next-generation sequencing. Clin Infect Dis 60:919-923. http://dx.doi.org/10.1093/cid/ciu912.
6. Hoffmann B, Tappe D, Höper D, Herden C, Boldt A, Mawrin C, Niederstrasser O, Müller T, Jenckel M, van der Grinten E, Lutter C, Abendroth B, Teifke JP, Cadar D, Schmidt-Chanasit J, Ulrich RG, Beer M. 2015. A variegated squirrel bornavirus associated with fatal human encephalitis. N Engl J Med 373:154-162. http://dx.doi.org/10.1056/ NEJMoa1415627.
7. Quan P, Wagner TA, Briese T, Torgerson TR, Hornig M, Tashmukhamedova A, Firth C, Palacios G, Baisre-De-Leon A, Paddock CD, Hutchison SK, Egholm M, Zaki SR, Goldman JE, Ochs HD, Lipkin WI. 2010. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis 16:918-925. http://dx.doi.org/10.3201/ eid1606.091536.
8. GenomeWeb. 7 August 2015. CDC earmarks $2.3 million for NGS, bioinformatic approaches to combat infectious disease. GenomeWeb, New York, NY. https://www.genomeweb.com/research-funding/cdcearmarks-23m-ngs-bioinformatic-approaches-combat-infectiousdisease.
9. Turabelidze G, Lawrence SJ, Gao H, Sodergren E, Weinstock GM, Abubucker S, Wylie T, Mitreva M, Shaikh N, Gautom R, Tarr PI. 2013. Precise dissection of an Escherichia coli O157:H7 outbreak by single nucleotide polymorphism analysis. J Clin Microbiol 51:3950-3954. http:// dx.doi.org/10.1128/JCM.01930-13.
10. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin C, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Møller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 365:709-717. http://dx.doi.org/10.1056/NEJMoa1106920.
11. Chin C, Sorenson J, Harris JB, Robins WP, Charles RC, Jean-Charles RR, Bullard J, Webster DR, Kasarskis A, Peluso P, Paxinos EE, Yamaichi Y, Calderwood SB, Mekalanos JJ, Schadt EE, Waldor MK. 2011. The origin of the Haitian cholera outbreak strain. N Engl J Med 364:33-42. http://dx.doi.org/10.1056/NEJMoa1012928.
12. Azarian T, Cook RL, Johnson JA, Guzman N, McCarter YS, Gomez N, Rathore MH, Morris JG, SalemiM. 2015. Whole-genome sequencing for outbreak investigations of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice? Infect Control Hosp Epidemiol 36:777-785. http://dx.doi.org/10.1017/ice.2015.73.
13. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116. http://dx.doi.org/10.1126/scitranslmed.3004129.
14. Dunne WM, Jr, Westblade LF, Ford B. 2012. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 31:1719-1726. http://dx.doi.org/ 10.1007/s10096-012-1641-7.
15. Stoesser N, Batty EM, Eyre DW, Morgan M, Wyllie DH, Del Ojo Elias C, Johnson JR, Walker AS, Peto TEA, Crook DW. 2013. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 68:2234-2244. http://dx.doi.org/10.1093/jac/dkt180.
16. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM. 2011. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365:892-900. http://dx.doi.org/10.1056/NEJMoa1011138.
17. Tran TT, Panesso D, Gao H, Roh JH, Munita JM, Reyes J, Diaz L, Lobos EA, Shamoo Y, Mishra NN, Bayer AS, Murray BE, Weinstock GM, Arias CA. 2013. Whole-genome analysis of a daptomycinsusceptible Enterococcus faecium strain and its daptomycin-resistant vari-ant arising during therapy. Antimicrob Agents Chemother 57:261-268. http://dx.doi.org/10.1128/AAC.01454-12.
18. Fisher R, van Zyl GU, Travers SAA, Kosakovsky Pond SL, Engelbrech S, Murrell B, Scheffler K, Smith D. 2012. Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen. J Virol 86:6231-6237. http://dx.doi.org/10.1128/JVI.06541-11.
19. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102:11070-11075. http://dx.doi.org/10.1073/pnas.0504978102.
20. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65. http://dx.doi.org/10.1038/nature08821.
21. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong M, Xu A, Chavakis T, Bornstein AB, Ehrhart-Bornstein M, Lamounier-Zepter V, Lohmann T, Wolf T, Bornstein SR. 2013. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenomics J 13:514-522. http://dx.doi.org/ 10.1038/tpj.2012.43.
22. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y, Wu Y, Schauer P, Smith JD, Allayee H, Tang WHW, DiDonato JA, Lusis AJ, Hazen SL. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57-63. http://dx.doi.org/10.1038/nature09922.
23. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O'Toole GA. 2013. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 1:27. http://dx.doi.org/10.1186/2049-2618-1-27.
24. Koren S, Schatz MC, Walenz BP, Martin J, Howard JT, Ganapathy G, Wang Z, Rasko DA, McCombie WR, Jarvis ED, Phillippy AM. 2012. Hybrid error correction and de novo assembly of single-molecule sequencing reads. Nat Biotechnol 30:693-700. http://dx.doi.org/10.1038/ nbt.2280.
25. Gordon NC, Price JR, Cole K, Everitt R, Morgan M, Finney J, Kearns AM, Pichon B, Young B, Wilson DJ, Llewelyn MJ, Paul J, Peto TEA, Crook DW, Walker AS, Golubchik T. 2014. Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing. J Clin Microbiol 52:1182-1191. http://dx.doi.org/10.1128/JCM.03117-13.
26. US Food and Drug Administration. 19 March 2015. Overview of IVD regulation. US Food and Drug Administration, Silver Spring, MD. http:// www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ IVDRegulatoryAssistance/ucm123682.htm.
27. US Food and Drug Administration. 18 February 2014. Requests for feedback on medical device submissions: the pre-submission program and meetings with Food and Drug Administration staff. US Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/ucm/ groups/fdagov-public/@fdagov-meddev-gen/documents/document/ ucm311176.pdf.
28. US Food and Drug Administration. 11 July 2014. Public workshop-advancing regulatory science for high throughput sequencing devices for microbial identification and detection of antimicrobial resistance markers, April 1, 2014. US Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ ucm386967.htm.
29. Collins FS, Hamburg MA. 2013. First FDA authorization for nextgeneration sequencer. N Engl J Med 369:2369-2371. http://dx.doi.org/ 10.1056/NEJMp1314561.
30. US Food and Drug Administration. 11 December 2013. FDA database for regulatory grade microbial sequences (FDA-ARGOS): supporting development and validation of infectious disease Dx tests. National Center for Biotechnology Information, Bethesda, MD. http:// www.ncbi.nlm.nih.gov/bioproject/231221.
31. Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DGB, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV. 2015. College of American Pathologists' laboratory standards for nextgeneration sequencing clinical tests. Arch Pathol Lab Med 139:481-493. http://dx.doi.org/10.5858/arpa.2014-0250-CP.
32. Sichtig H. 2014. High-throughput sequencing technologies for microbial identification and detection of antimicrobial resistance markers, p 1-21. In FDA Public Workshop on High Throughput Sequencing Devices in Microbial Diagnostics. US Food and Drug Administration, Silver Spring, MD.
33. Olson N, Zook J, Vang L, Catoe D, McDaniel J, Salit M. 11 April 2014. Microbial genomic reference materials. US Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/downloads/MedicalDevices/ NewsEvents/WorkshopsConferences/UCM393056.pdf.
34. Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E. 2013. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15: 733-747. http://dx.doi.org/10.1038/gim.2013.92.
35. Fricke WF, Rasko DA. 2014. Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet 15:49-55. http:// dx.doi.org/10.1038/nrg3624.
36. Didelot X, Bowden R, Wilson DJ, Peto TEA, Crook DW. 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 13:601-612. http://dx.doi.org/10.1038/nrg3226.